Navigation Links
ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
Date:9/27/2007

SAN DIEGO, Sept. 27 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, announced today that data from preclinical studies of ANX-514 (docetaxel emulsion) will be presented at the American Association of Cancer Research (AACR), National Cancer Institute (NCI) and European Organization and Treatment of Cancer (EORTC) International Conference "Molecular Targets and Cancer Therapeutics" in San Francisco, October 22-26, 2007. The abstract entitled "A novel emulsion formulation of docetaxel eliminates hypersensitivity reactions without impacting pharmacokinetics or antitumor activity" will be presented on October 25, 2007 at 12:30p.m. Pacific Standard Time.

ANX-514 is a novel emulsion formulation of docetaxel. Docetaxel is an anti-cancer agent that is approved to treat breast, non-small cell lung, prostate, gastric and head and neck cancers, and is marketed under the brand name Taxotere(R). Annual sales of Taxotere in 2006 were approximately $2.2 billion.

ADVENTRX recently received confirmation from the U.S. Food and Drug Administration (FDA) regarding its proposed 505(b)(2) New Drug Application (NDA) regulatory plan for ANX-514 (docetaxel emulsion). The FDA indicated that data from a single study of approximately 28 patients that demonstrates the bioequivalence of ANX-514 and Taxotere is sufficient to support filing an NDA.

About ANX-514 (docetaxel emulsion)

ANX-514 is a novel nano-emulsion formulation of the chemotherapy drug docetaxel, a product marketed under the brand name Taxotere. ANX-514 is formulated without poly
'/>"/>

SOURCE ADVENTRX Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Four of the top 10 pharmaceutical giants us...ns to Health Canada. Datafarm’s announcement...ian DIA Annual Meeting where Health Canada stated ... submit Hybrid eCTD regulatory submissions for New...permission request. , Mar...
(Date:11/8/2009)... As global temperatures and energy costs continue ...o a sustainable future. An attractive replacemen...ished online in Genome Research ( www.genome.org... of bioethanol-producing microorganisms, uncoverin...g new technologies needed to implement production ...
(Date:11/6/2009)... 6 /PRNewswire-FirstCall/ - Microbix Biosystems In...filed the Form 52-109F1 Certification of Annual Fi...er and James Long, the Chief Financial Officer (th... in connection with the annual audited financial s..., The Company initially filed the annual financ...
(Date:11/6/2009)..., Nov. 6 Myriant Technologies LLC ...nd manufacturer of renewable bio-chemicals, Uhde ...y provider Uhde GmbH, one of the world,s leading e... an alliance for the engineering, procurement &...c Acid plants based on renewable feedstocks. The ...
Breaking Biology Technology:Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3
...o announce the,fall conference line up which cover...e pharmaceutical industry today. The events that a...rking opportunities for Clinical,Marketing, R&D, a...pharmaceutical, biotech and medical technology com...eatured events and highlights,from those conferenc...
...s Experience to the Leader in C...s., Aug. 10 Seahorse Bioscience, the,leading prov...r,bioenergetics in microplates, announced today th...n has been appointed to the company,s Board of,Dir...ccessful business,experience in the life sciences ...
...trengthens Kendle,s Global Regu... Kendle (Nasdaq: KNDL ), a,leading, global full-s...nced that Timothy Forsey, PhD, has joined the comp...cializing in providing regulatory affairs,guidance...n Kendle,s Ely,Cambridgeshire, England office, he ...
Other Biology Technology:Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharma's Fall Line Up! 2Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors 2Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant 2Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant 3
(Date:11/9/2009)... Rice University evolutionary biologists David Qu...t high cooperation and low conflict between compon...thing its "organismality," whether that thing is a...me of the traits scientists use to describe an org... the same species, may not be necessary to achieve...
(Date:11/9/2009)... Delft, the Netherlands, November 09, 2009 / b3c ...ch organization, and Seventh Wave, an American org...nnounce that the companies have signed a letter of...trointestinal models TIM. The letter of intent pro...btain two TIM systems for commercialization in Nor...
(Date:11/8/2009)... , HOUSTON - (Nov. 8, 2009) The loss of a gene ... 15 is associated with significant abnormalities i...archers led by Baylor College of Medicine ( www.bc...he journal Nature Genetics . , "This research g...roblems in a specific group of individuals to this...
Breaking Biology News(10 mins):What is the meaning of 'one'? 2What is the meaning of 'one'? 3TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Developmental delay could stem from nicotinic receptor deletion 2Pennsylvania Department of Health Applauds New Federal Anti Tobacco Law 49680 1Pennsylvania Department of Health Applauds New Federal Anti Tobacco Law 49680 2Courage Camps Maintain Summer Camp Schedule for Children and Adults With Disabilities 49677 1Courage Camps Maintain Summer Camp Schedule for Children and Adults With Disabilities 49677 2Assurant to Announce 2009 Second Quarter Results July 29 2009 and Host Webcast Conference Call July 30 49674 1Assurant to Announce 2009 Second Quarter Results July 29 2009 and Host Webcast Conference Call July 30 49674 2
...egion of monoclonal antibodies (mAbs) increases th...g the utility of targeted cancer therapies, accord... published in the March 14 print issue of the Proc.... , Monoclonal antibodies have important advantag...ments for cancer, such as their specificity in tar...
...gists have uncovered intriguing evidence to suppor...In a study of baboons, scientists showed that as t...ir skin significantly increases. , Over time, cell...eplicative senescence. The new research, published...first to quantify the presence of replicatively se...
...iversity of Queensland report in the journal Geno...me are conspicuously devoid of ubiquitous mobile D...these regions are highly conserved among mammalian... regulation of developmental processes. , Transpos...es that have the capacity to move from one chromos...
Other Biology News:Data published in PNAS show antibodies can be made 10 times more toxic to cancer cells 2Aging cells, aging body: Fresh evidence for a connection 2Where 'jumping genes' fear to tread 2
Peptone from Sigma-Aldrich
...2 cells were cultured in Minimum Essential Medium ... log phase of growth. In order to keep the antige...one-methanol. The cells are arrayed on a 12-well ...ace specifically treated to enhance cellular attac...
...ells were cultured in Minimum Essential Medium (Ea...g phase of growth. In order to keep the antigens ...-methanol. The cells are arrayed on a 12-well (5 ... specifically treated to enhance cellular attachme...
...Plus Microsphere/Microarray Stabilizer is an aqueo...n and other non-toxic chemicals in a PBS buffer (p...uct contains a combination of 0.02% methylisothiaz...e. StabilCoat Plus Stabilizer provides optimum pe...
Biology Products: